- 全部删除
 
您的购物车当前为空
JX237 是一种高效的上皮中性氨基酸转运蛋白 B0AT1 (SLC6A19) 抑制剂,是中兴氨基酸被肝脏吸收的转运蛋白,可用于研究心血管疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
JX237 是一种高效的上皮中性氨基酸转运蛋白 B0AT1 (SLC6A19) 抑制剂,是中兴氨基酸被肝脏吸收的转运蛋白,可用于研究心血管疾病。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 315  | In stock | |
| 5 mg | ¥ 745  | In stock | |
| 10 mg | ¥ 1,320  | In stock | |
| 25 mg | ¥ 2,650  | In stock | |
| 50 mg | ¥ 4,290  | In stock | |
| 100 mg | ¥ 5,970  | In stock | |
| 200 mg | ¥ 8,220  | In stock | 
JX237 相关产品
| 产品描述 | JX237 is a potent inhibitor of the epithelial neutral amino acid transporter protein B0AT1 (SLC6A19), a transporter protein for the uptake of neutralizing amino acids by the liver, and can be used in the study of cardiovascular disease.  | 
| 别名 | JX 237 | 
| 分子量 | 271.15 | 
| 分子式 | C11H15BrN2O | 
| CAS No. | 1021125-90-5 | 
| Smiles | O=C(NCC)CNC1=CC=C(Br)C(=C1)C | 
| 颜色 | Yellow | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200.00 mg/mL (737.60 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容